Washington, DC 20006-5349
HELPLINE
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
Conversation with Travis Grotz, MD, surgical oncologist at Mayo Clinic who specializes in the treatment of peritoneal malignancies. Dr. Grotz serves on the Science Advisory
Separately, chemotherapy and immunotherapy are both approved to treat mesothelioma, and individually they work equally well for those patients with the epithelioid type of disease.
Watch this episode on YouTube. In this episode of MesoTV, we meet with Joseph Friedberg, MD, FACS, a thoracic surgeon at Temple University Hospital-Main Campus
Mesothelioma community member, patient, and Meso Foundation’s board member, Jessica Blackford-Cleeton just concluded her participation in the review process for the Congressionally Directed Medical Research
Last week, the Polaris Group announced positive results of its Phase 2/3 clinical trial evaluating the effectiveness of an arginine degrading enzyme agent called ADI-PEG 20.
On this Mesothelioma Awareness Day, the mesothelioma community will once again work in their local communities to light the world blue! As part of this
The Mesothelioma Applied Research Foundation is proud to announce the recipients of its most recent round of new mesothelioma research funding. Through a rigorous review
On July 22 and 23rd, the mesothelioma community once again gathered at the Mesothelioma Applied Research Foundation’s International Symposium on Malignant Mesothelioma (also known more